New York, NY (PRWEB) May 25, 2013
On May 25, Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, comments on a new study by the Max Planck Institute for Extraterrestrial Physics, that shows incorporating cold atmospheric plasma into brain cancer treatment may help when dealing with glioblastoma cells.
According to a Science Daily article, physicists from the Max Planck Institute for Extraterrestrial Physics (MPE), biologists and physicians demonstrated the “synergistic effect of cold atmospheric plasma -- a partly ionized gas -- and chemo therapy on aggressive brain tumor cells.” Lab tests in the study showed that the production of glioblastoma cells was blocked and resistant cell populations became sensitive to treatment with chemo therapy when pre-treated with cold atmospheric plasma. A Glioblastoma is the most common and aggressive form of a brain tumor. The success of the cold atmospheric plasma (CAP) could be the primary step in creating a new combination therapy which would provide hope for finding a cure to brain cancer.
CAP has already proven to successfully disable bacteria, viruses and fungi while keeping remaining healthy tissue unaffected. For the recent study, researchers used glioblastoma cells and grew them in cell culture dishes. According to the article, “for both normal and resistant tumor cell lines, the growth of the cells was inhibited after the plasma treatment compared to the chemotherapy alone.” Researchers also found that “CAP stops the cell cycle and that the individual cells lose their ability to clone themselves.”
Julia Koritzer, the lead author of the study, told Science Daily, “Resistant cell populations could be treated effectively with CAP, which means that there is now hope to find a therapy for the patients with a poor prognosis. It is a first step, now we have to further investigate the effects gained in the cell culture and integrate them for the application.”
Michael Klipper, chairman of Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, sees the promise in this discovery. “Even though it will probably be a good amount of time before CAP can be used in hospitals and for actual treatment, it offers those who are affected by this deadly disease hope for a possibility for a cure in the future.”
VABC has a wide variety of initiatives in place for brain cancer research, awareness and support. The organization’s research grants fund cutting-edge research programs that will have a monumental impact on the diagnosis and treatment of brain cancer. VABC currently funds research at several esteemed institutions such as Brookhaven National Laboratory, Cleveland Clinic, Columbia, Cornell, Duke, Harvard, John Hopkins, Memorial Sloan-Kettering and Yale, to name a few.
VABC's mission is to find a cure for brain cancer by advancing scientific research, increasing awareness within the medical community and supporting patients, their families and caregivers afflicted with this devastating disease.
For press inquiries, please contact: 5W Public Relations